Division of Gastroenterology and HepatologyStanford UniversityStanfordCAUSA.
VA Palo Alto Health SystemPalo AltoCAUSA.
Hepatol Commun. 2021 Apr 9;5(4):553-555. doi: 10.1002/hep4.1662. eCollection 2021 Apr.
This is an editorial about non-invasive fibrosis markers in patients with NASH and type 2 diabetes mellitus.
这是一篇关于 NASH 和 2 型糖尿病患者非侵入性纤维化标志物的社论。